/global-hiv-hepatitis-and-stis-programmes-(hhs)/collaborative-actions-en1.png?sfvrsn=8903764_7 "collaborative-actions-en1")
HIV Country Intelligence
/global-hiv-hepatitis-and-stis-programmes-(hhs)/lusophone-country-collaboration-banner.tmb-1920v.png?sfvrsn=83494cc1_3)
Lusophone countries collaboration to eliminate HIV, hepatitis, STIs and TB
Portuguese-speaking nations, home to over 270 million people, face significant public health challenges, including the goal of eliminating HIV, sexually transmitted infections (STIs), hepatitis, and tuberculosis (TB) by 2030. However, many struggle with limited access to essential resources, often due to a lack of materials in Portuguese.
This webpage serves as a platform to promote the elimination of HIV, viral hepatitis, STIs, and TB in Lusophone countries through the dissemination of information, resources and experiences between countries.
Explore the latest resources, join upcoming events, and access national guidelines on combating these diseases.
News and features
Webinars and events
25 October 2024
Eliminating HIV, viral hepatitis, sexually transmitted infections and tuberculosis...
This report summarizes the outcomes of the meeting of lusophone countries held from 12 to 14 March 2024 in Brasília, Brazil focusing on integrated responses...
Participating countries
Country collaborative actions
In the March 2024 meeting, Angola, Brazil, Cabo Verde, Guinea Bissau, Mozambique, Portugal and São Tomé e Principe had the opportunity to share preliminary collaborative plans, focusing on priority areas, types of collaboration and possible types of country interactions.
Global guidance
The Guidance on evidence generation (GEG) on new regimens for tuberculosis treatment is a first-of-its-kind document that advises researchers, developers,...
4 December 2024
Priorities in planning person-centred hepatitis B and C testing services: operational guide
This operational guide on viral hepatitis testing services provides support to countries in developing policies and practices that define a ...
These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...
17 July 2024
Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema...
The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis...
This report is the first of a series of biennial progress reports on the implementation of the Global health sector strategies on HIV, viral hepatitis...
1 March 2024
Introducing a framework for implementing triple elimination of mother-to-child transmission of HIV, syphilis...
Triple elimination of mother-to-child transmission (MTCT) of HIV, syphilis and hepatitis B virus (HBV) requires a person- centred service delivery approach...
/global-hiv-hepatitis-and-stis-programmes-(hhs)/guidelines-on-hiv--hepatitis-and-stis-for-key-populations.tmb-144v.png?sfvrsn=e427e1d3_6)
29 July 2022
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response...
16 July 2021
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations...
These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and...
National guidance
Please consult the page in Portuguese to access national resources and guidance.
Country profiles
HIV Country Intelligence
Tools and toolkits
/global-hiv-hepatitis-and-stis-programmes-(hhs)/hivst-zimbabwe-afro-nologo-1920.jpg?sfvrsn=a70f3d5b_2 "hivst-zimbabwe-afro-nologo-1920")
Self-testing implementation toolkit for HIV, hepatitis C and syphilis
Training
Disclaimer
The provision of national guidance and other materials, including links from other websites is provided for your convenience and does not indicate endorsement of those materials or sites by WHO. WHO accepts no responsibility for the validity or accuracy of their content. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned.